Document
IPR2016-00098, No. 8 Preliminary Response - Cephalon, Incs Preliminary Patent Owner Response Pursuant to 37 CFR 42107 (P.T.A.B. Feb. 8, 2016)
Cite Document
IPR2016-00098, No. 8 Preliminary Response - Cephalon, Incs Preliminary Patent Owner Response Pursuant to 37 CFR 42107 (P.T.A.B. Feb. 8, 2016)
+ More Snippets
Document
IPR2016-00098, No. 7 Preliminary Response - Expunged (P.T.A.B. Feb. 5, 2016)
Cite Document
IPR2016-00098, No. 7 Preliminary Response - Expunged (P.T.A.B. Feb. 5, 2016)
+ More Snippets
Document
IPR2016-00026, No. 6 Notice - Related Matters (P.T.A.B. Oct. 30, 2015)
Cite Document
IPR2016-00026, No. 6 Notice - Related Matters (P.T.A.B. Oct. 30, 2015)
+ More Snippets
Document
IPR2016-00026, No. 5 Power of Attorney - Power of Attorney (P.T.A.B. Oct. 30, 2015)
Cite Document
IPR2016-00026, No. 5 Power of Attorney - Power of Attorney (P.T.A.B. Oct. 30, 2015)
+ More Snippets
Document
IPR2016-00026, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Oct. 9, 2015)
Cite Document
IPR2016-00026, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Oct. 9, 2015)
+ More Snippets
Document
IPR2016-00026, No. 2 Notice - Related Matters (P.T.A.B. Oct. 9, 2015)
Cite Document
IPR2016-00026, No. 2 Notice - Related Matters (P.T.A.B. Oct. 9, 2015)
+ More Snippets
Document
IPR2016-00098, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. Nov. 18, 2015)
Cite Document
IPR2016-00098, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. Nov. 18, 2015)
+ More Snippets
Document
IPR2016-00098, No. 5 Notice - Related Matters (P.T.A.B. Nov. 18, 2015)
Cite Document
IPR2016-00098, No. 5 Notice - Related Matters (P.T.A.B. Nov. 18, 2015)
+ More Snippets
Document
IPR2016-00098, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Oct. 28, 2015)
Cite Document
IPR2016-00098, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Oct. 28, 2015)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241RP1 (U.S. Pat. App. Feb. 3, 2021)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241RP1 (U.S. Pat. App. Feb. 3, 2021)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241QP1 (U.S. Pat. App. Jan. 21, 2021)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241QP1 (U.S. Pat. App. Jan. 21, 2021)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241PP1 (U.S. Pat. App. Jan. 12, 2021)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241PP1 (U.S. Pat. App. Jan. 12, 2021)
+ More Snippets
Document
BELRAPZO, 205580, Letter (Orange Book Oct. 30, 2019)
Cite Document
BELRAPZO, 205580, Letter (Orange Book Oct. 30, 2019)
+ More Snippets
Document
BELRAPZO, 205580, Label (Orange Book Oct. 30, 2019)
Cite Document
BELRAPZO, 205580, Label (Orange Book Oct. 30, 2019)
+ More Snippets
Document
TREANDA, 022249, Label (Orange Book Nov. 21, 2019)
Cite Document
TREANDA, 022249, Label (Orange Book Nov. 21, 2019)
+ More Snippets